CapsoVision Closes $14M Private Placement Financing
CapsoVision on Friday announced the closing of a $14M private placement in public equity financing pursuant to a securities purchase agreement entered into by the company with selected accredited investors on March 16, for such investors to purchase shares of common stock of the company. The company agreed to sell 2,867,089 shares of common stock of the company, with par value $0.001 per share, at $4.883 per share, which represents a 5% discount to the March 16 closing price, as per the terms of the agreement, the company said. CapsoVision said it expects to use the net proceeds from the private placement for general corporate purposes, including sales and marketing, research and development activities, general and administrative matters, and working capital. On Friday, CapsoVision also announced preliminary results, including fourth quarter revenue of $3.9M and full year 2025 revenue of $13.6M. As of December, 31, 2025, the company had preliminary cash, cash equivalents, restricted cash and investments of approximately $10.1M. Following the preliminary results and private placement, Roth Capital raised the firm's price target on CapsoVision to $11 from $7 and keeps a Buy rating on the shares. Shares of CapsoVision are up nearly 21% in morning trading to $8.30.
